2005
Top
Vol. 4
November November 2005 No. 8, p1
Expert Report on Optimising Hormonal Control in Prostate Cancer
October October 2005 No. 7, p1
Omnic OCAS®: Proceedings of the European Launch Symposium, Reykjavik, Iceland, 11 February 2005
August August 2005 No. 6, p1
Would you recognize LOH if it walked into your practice? Diagnosis and management of late-onset hypogonadism
July July 2005 No. 5, p1
Prostate Cancer: Testosterone Suppression Levels and Eligard®
March March 2005 No. 4, p1
Controversies in the Management of Bladder Cancer and Prostate Cancer
March March 2005 No. 3, p3
XXth Congress of the European Association of Urology
February February 2005 No. 2, p1
OCAS: The Evolution of Tamsulosin for the Treatment of LUTS/BPH
January January 2005 No. 1, p1
Management of stress urinary incontinence in women: challenges and new perspectives
2004
Top
Vol. 3
November November 2004 No. 5, p1
Bone Complications in Prostate Cancer: The Clinical Role of Zoledronic Acid
September September 2004 No. 4, p1
Integrating Patient Risk Profiles: The Future Management of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
March March 2004 No. 3, p1
Urological Malignancies: From Diagnosis to Treatment. First Fall Meeting of the European Society of Oncological Urology (ESOU)
February February 2004 No. 2, p1
XIXth Congress of the European Association of Urology
February February 2004 No. 1, p1
Hormonal Management of Prostate Cancer: Current Status and Future Developments
2003
Top
Vol. 2
December December 2003 No. 10, p1
Sexuality: A Vital Aspect for the BPH Patient. Satellite Symposium held during the XVIIIth Congress of the EAU
December December 2003 No. 9, p1
Prostate Cancer Treatment on Trial
November November 2003 No. 8, p1
Facing the Challenges of BPH Management. Satellite symposia held during the XVIIth and XVIIIth Congresses of the EAU
November November 2003 No. 7, p1
Managing Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH): The Total Approach
September 24 September 2003 No. 6, p1
September September 2003 No. 5, p1
Overactive Bladder: Reviewing the Evidence
September September 2003 No. 4, p1
New Aspects in the Treatment of Interstitial Cystitis
March March 2003 No. 3, p1
Revolutions in the Management of Hormone-Refractory Prostate Cancer
March March 2003 No. 2, p1
International Consensus Conference on Advances in the Diagnosis and Treatment of Prostatitis
February February 2003 No. 1, p1
XVIIIth Congress of the European Association of Urology
2002
Top
Vol. 1
December December 2002 No. 10, p1
The Use of Biomaterials in Urology (Satellite Symp. of XVIIth Congr. EAU, February 23, 2002, Birmingham, UK) and Female Urology, New Understanding, New Approaches, New Materials (Satellite Symp. of XIth European Urological Winter Forum)
November November 2002 No. 9, p1
Lower Urinary Tract Symptoms: The Paradigm Shift. New Perspectives in Aetiology and Outcome. Proceedings of a Satellite Symposium held at the XVIIth Congress of the EAU, February 25, 2002, Birmingham, UK
November November 2002 No. 8, p1
Advances in the Treatment of Erectile Dysfunction, XVIIth Congress of the EAU, February 23, 2002, Birmingham, UK
October October 2002 No. 7, p1
Prostate Cancer - Life after Diagnosis, 29-30 November 2001, Nice, France
September September 2002 No. 6, p1
Transrectal Ultrasound Prostatic Biopsy in the PSA Era
August August 2002 No. 5, p1
PSA Change Predicts Survival - Fact or Fiction? EAU, February 24, 2002, Birmingham, UK
July July 2002 No. 4, p1
Overactive Bladder: New Perspectives
May May 2002 No. 3, p1
The Evolution of Apomorphine SL in the Management of Erectile Dysfunction (ED)
May May 2002 No. 2, p1
January January 2002 No. 1, p3
